NeuroSync (formerly SyncThink)
About NeuroSync (formerly SyncThink)
NeuroSync (formerly SyncThink) is a neurotechnology company at the forefront of digital health, leveraging artificial intelligence (AI) and objective measures to advance brain health and performance. The company’s core offering, EYE-SYNC, is an FDA-cleared eye-tracking software integrated with virtual reality (VR) headsets. This platform provides clinicians, researchers, and high-performance specialists with rapid, accurate, and reliable data by analyzing eye movements to identify neurological deficits, monitor treatment efficacy, and inform personalized training regimens.
For physicians, NeuroSync’s technology offers a crucial tool for objective assessment in areas traditionally reliant on subjective evaluation. Its applications span a wide range of neurological conditions, including the diagnosis and monitoring of concussions and post-concussion syndrome, particularly in athletic populations. Beyond sports, the platform is relevant for cognitive functioning in age-associated neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease, autoimmune disorders like Multiple Sclerosis, and developmental disorders including ADHD and autism. NeuroSync also provides PRO-SYNC, a solution aimed at managing brain performance and visual processing, which can assist in identifying mental acuity areas and sleep quality, further supporting comprehensive patient care and performance optimization.
Focus Areas
Business Intelligence
| Key Investors | Quadrant Management, MassChallenge |
| Partnerships | XFL, Pico Interactive, Tobii, Magic Leap, Department of Defense, Microsoft, Stanford University, Pac-12 Conference, University of Texas, Golden State Warriors |
| Technology | Digital health platform, Artificial Intelligence (AI), objective measures, eye-tracking technology (EYE-SYNC), Virtual Reality (VR)/Extended Reality (XR) headsets, proprietary algorithms, cloud-based solution, Android-based software application |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, NeuroSync's EYE-SYNC platform offers objective, rapid (60-second assessments) and actionable data for neurological assessment, moving beyond subjective symptom-based evaluations. Its FDA clearance as an aid to concussion diagnosis, including the ability to identify impairments without a baseline test, is particularly valuable in acute care settings. The platform's expansion into neurodegenerative and developmental disorders, coupled with its therapeutic modalities, positions it as a comprehensive tool for both diagnosis and ongoing patient management. The cloud-connected, HIPAA-compliant analytics ensure secure data management and customizable reports support informed clinical decision-making.
NeuroSync's EYE-SYNC platform is delivered via modified Virtual Reality (VR) headsets (e.g., Pico Neo 3 Pro Eye, Oculus VR) and is expanding into Augmented Reality (AR) platforms through partnerships (e.g., Magic Leap). The system connects wirelessly to a tablet for clinician control and report generation, and its adaptable architecture allows for potential integration with electronic medical records (EMR) and other sports performance sensors.
Reviews & Opinions
Videos
News, demos, and interviews about NeuroSync (formerly SyncThink).
Videos load interactively. If none appear, search YouTube for NeuroSync (formerly SyncThink) →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]